Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-09 4:17 pm Purchase | 2025-12-08 | 13D | vTv Therapeutics Inc. VTVT | Samsara BioCapital, L.P. | 403,942 9.900% | 60,719 (+17.69%) | Filing History |
| 2025-11-24 6:54 pm Purchase | 2025-11-18 | 13D | Alumis Inc. Common Stock ALMS | Samsara BioCapital, L.P. | 5,134,991 5.300% | 367,081 (+7.70%) | Filing History |
| 2025-11-24 6:48 pm Sale | 2025-11-20 | 13D | Nkarta, Inc. NKTX | Samsara BioCapital, L.P. | 3,507,666 4.900% | -260,369 (-6.91%) | Filing History |
| 2025-11-19 8:52 pm Purchase | 2025-11-17 | 13D | Inventiva S.A. IVA | Samsara BioCapital, L.P. | 13,540,194 7.400% | 5,378,252 (+65.89%) | Filing History |
| 2025-11-17 4:56 pm Sale | 2025-11-13 | 13D | Alumis Inc. Common Stock ALMS | Samsara BioCapital, L.P. | 4,767,910 4.900% | -33,460 (-0.70%) | Filing History |
| 2025-11-14 5:26 pm Sale | 2025-09-30 | 13G | CARGO Therapeutics, Inc. Common Stock CRGX | Samsara BioCapital, L.P. | 0 0.000% | -4,415,689 (Position Closed) | Filing History |
| 2025-10-30 7:50 pm Purchase | 2025-10-23 | 13D | Rani Therapeutics Holdings, Inc. RANI | Samsara BioCapital, L.P. | 9,882,477 9.900% | 9,882,477 (New Position) | Filing History |
| 2025-10-21 4:07 pm Purchase | 2025-05-07 | 13D | Inventiva S.A. IVA | Samsara BioCapital, L.P. | 8,161,942 5.900% | 8,161,942 (New Position) | Filing History |
| 2025-10-07 9:00 pm Purchase | 2025-10-03 | 13D | Scholar Rock Holding Corporation SRRK | Samsara BioCapital, L.P. | 6,991,553 7.200% | 234,298 (+3.47%) | Filing History |
| 2025-09-25 5:06 pm Unchanged | 2025-09-22 | 13D | vTv Therapeutics Inc. VTVT | Samsara BioCapital, L.P. | 343,223 9.900% | 0 (Unchanged) | Filing History |
| 2025-09-08 8:05 pm Purchase | 2025-09-04 | 13D | Mineralys Therapeutics, Inc. MLYS | Samsara BioCapital, L.P. | 6,346,194 8.200% | 609,889 (+10.63%) | Filing History |
| 2025-09-03 7:33 pm Purchase | 2025-08-29 | 13D | vTv Therapeutics Inc. VTVT | Samsara BioCapital, L.P. | 343,223 9.900% | 77,603 (+29.22%) | Filing History |
| 2025-08-14 5:28 pm Unchanged | 2025-06-30 | 13G | Cypherpunk Technologies Inc. CYPH | Samsara BioCapital, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-08-14 5:28 pm Sale | 2025-06-30 | 13G | OnKure Therapeutics, Inc. OKUR | Samsara BioCapital, L.P. | 0 0.000% | -824,155 (Position Closed) | Filing History |
| 2025-08-14 5:26 pm Sale | 2025-06-30 | 13G | Palvella Therapeutics, Inc. PVLA | Samsara BioCapital, L.P. | 339,743 3.100% | -339,743 (-50.00%) | Filing History |
| 2025-05-23 8:49 pm Purchase | 2025-05-21 | 13D | Alumis Inc. Common Stock ALMS | Samsara BioCapital, L.P. | 4,801,370 5.000% | 4,801,370 (New Position) | Filing History |
| 2025-03-27 6:17 pm Sale | 2024-11-18 | 13D | Syros Pharmaceuticals, Inc. SYRS | Samsara BioCapital, L.P. | 707,114 2.600% | -1,808,409 (-71.89%) | Filing History |
| 2025-03-25 7:40 pm Purchase | 2025-03-18 | 13D | Kalaris Therapeutics Inc KLRS | Samsara BioCapital, L.P. | 11,448,081 61.200% | 11,448,081 (New Position) | Filing History |
| 2025-03-17 9:06 pm Purchase | 2025-03-13 | 13D | Mineralys Therapeutics, Inc. MLYS | Samsara BioCapital, L.P. | 5,736,305 9.100% | 644,278 (+12.65%) | Filing History |
| 2025-02-14 5:54 pm Sale | 2024-12-31 | 13G | IO Biotech, Inc. IOBT | Samsara BioCapital, L.P. | 2,631,578 3.800% | -1,008,437 (-27.70%) | Filing History |